We are a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker’s unique cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize multiple tumor associated antigens (multiTAA) and kill tumor cells expressing those targets. Once infused into patients, this population of multiTAA-specific T cells attacks multiple tumor targets and acts to activate the patient’s immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cells, when compared to current engineered CAR-T and TCR-based approaches, its products (i) are significantly less expensive and easier to manufacture, (ii) appear to be markedly less toxic, and (iii) are associated with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling therapeutic product profile, as compared to current gene-modified CAR-T and TCR-based therapies.
Company Details
- Employees
- 27
- Founded
- -
- Address
- 4551 Kennedy Commerce Dr, Houston,texas 77032,united States
- Phone
- (713) 400-6400
- in****@****ics.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- markertherapeutics.com
- HQ
- Houston, Texas
Marker Therapeutics, Inc. Questions
Marker Therapeutics, Inc.'s helpline number is (713) 400-6400
Marker Therapeutics, Inc.'s website is markertherapeutics.com
Marker Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/marker-therapeutics
Marker Therapeutics, Inc. has
27 employees.
View email and phone details for 27
employees at Marker Therapeutics, Inc..
Marker Therapeutics, Inc.'s industry is
Pharmaceutical Manufacturing
Marker Therapeutics, Inc.'s top competitors are
Moleculin Biotech, Inc.,
Bellicum Pharmaceuticals, Inc.,
Ctmc,
Immatics,
Cellipont Bioservices,
Ingeneron,
Cellready™,
Celltex Therapeutics Corporation,
Kiromic Biopharma, Inc.,
Kano Therapeutics.
Marker Therapeutics, Inc.'s support email address is investor.relations@markertherapeutics.com
Marker Therapeutics, Inc.'s categories are Pharmaceutical Manufacturing
Marker Therapeutics, Inc.'s founding year is 2018
